Manufacturers Life Insurance Company, The Uni Qure N.V. Transaction History

Manufacturers Life Insurance Company, The

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$11.12 - $22.2 $43,879 - $87,601	-3,946 Reduced 17.42%	18,700 $214,000
Q2 2022 Aug 11, 2023	SELL	$13.15 - $20.45 $11,085 - $17,239	-843 Reduced 3.59%	22,646 $422,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $11,085 - $17,239	-843 Reduced 3.59%	22,646 $418,000
Q1 2022 Aug 11, 2023	BUY	$14.54 - $21.5 $341,530 - $505,013	23,489 New	23,489 $424,000
Q1 2022 Aug 15, 2022	BUY	$14.54 - $21.5 $341,530 - $505,013	23,489 New	23,489 $420,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.